A combination of ezetimibe and a moderate-intensity statin seems to be a good alternative to high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (ASCVD), results ...
A combination of simvastatin and ezetimibe (Vytorin) lowered cholesterol better than simvastatin alone, but it had no effect on arterial plaque in a major clinical trial. As a result, cardiologists ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results